医学
内科学
心脏病学
心肌梗塞
ST段
经皮冠状动脉介入治疗
射血分数
舒张期
蒂米
心肌梗死并发症
危险系数
梗塞
狼牙棒
作者
Tuan L. Nguyen,Justin Phan,Jarred Hogan,Leia Hee,Daniel Moses,James Otton,U. Premawardhana,Rohan Rajaratnam,Craig P. Juergens,H. Dimitri,John K. French,David Richards,Liza Thomas
标识
DOI:10.1016/j.ahj.2016.05.020
摘要
Objectives We sought to determine the relationship of adverse diastolic remodeling (ie, worsening diastolic or persistent restrictive filling) with infarct scar characteristics, and to evaluate its prognostic value after ST-segment elevation myocardial infarction (STEMI). Background Severe diastolic dysfunction (restrictive filling) has known prognostic value post STEMI. However, ongoing left ventricular (LV) remodeling post STEMI may alter diastolic function even if less severe. Methods and results There were 218 prospectively recruited STEMI patients with serial echocardiograms (transthoracic echocardiography) and cardiac magnetic resonance imaging (CMR) performed, at a median of 4 days (early) and 55 days (follow-up). LV ejection fraction and infarct characteristics were assessed by CMR, and comprehensive diastolic function assessment including a diastolic grade was evaluated on transthoracic echocardiography. ‘Adverse diastolic remodeling' occurred if diastolic function grade either worsened (≥1 grade) between early and follow-up imaging, or remained as persistent restrictive filling at follow-up. Follow-up infarct scar size (IS) predicted adverse diastolic remodeling (area under the curve 0.86) and persistent restrictive filling (area under the curve 0.89). The primary endpoint of major adverse cardiovascular events (MACE) occurred in 48 patients during follow-up (mean, 710±79 days). Kaplan-Meier analysis showed that adverse diastolic remodeling (n=50) and persistent restrictive filling alone (n=33) were significant predictors of MACE (both P P P =.019). Conclusions Larger IS is associated with adverse diastolic remodeling. Following STEMI, adverse diastolic remodeling is a powerful prognostic marker, and identifies a larger group of ‘at-risk' patients, than does persistent restrictive filling alone.
科研通智能强力驱动
Strongly Powered by AbleSci AI